Green Cross LabCell, 14.48% Rise Amid Cord Blood Theme Uptrend

On the 7th, the umbilical cord blood theme rose by 3.45% compared to the previous day, showing strength, while Green Cross LabCell, which is attracting attention as a related stock, surged by 14.48% compared to the previous day. Green Cross LabCell is known as a cell therapy research and development company.

[Graph] Price Fluctuations of Major Stocks in the Umbilical Cord Blood Theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Green Cross LabCell ranked 2nd out of 7 stocks in the quant financial ranking by exceeding the theme's average scores in growth, stability, and profitability. This can be interpreted as Green Cross LabCell having a relatively high investment attractiveness compared to other stocks within the theme from a financial perspective.

[Table] Top Stocks by Financial Scores within the Theme

※ The quant financial scores are the results of the robo algorithm's analysis based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.